Cambridge Nutritional Sciences plc (CNSL.L)
LSE · GBp · Healthcare · Medical Instruments & Supplies
£1.55 (+0.00%) as of
Key statistics
- Market cap
- 3.69M
- Forward P/E
- -3.69
- EPS (TTM)
- -0.0200
- Dividend yield
- 0.00%
- 52-week range
- 1.2550 – 2.8000
- Beta
- 1.89
- Revenue (TTM)
- 6.97M
- Profit margin
- -83.53%
- Analyst target
- £3.00
- Volume
- 44.98k
About Cambridge Nutritional Sciences plc
Cambridge Nutritional Sciences plc, together with its subsidiaries, develops, manufactures, and distributes medical diagnostics products for the food sensitivity testing market in the United Kingdom, rest of Europe, the Americas, India, rest of Asia and the Far East, Africa, and the Middle East. The company is involved in the research, development, and production of kits for detection of immune reactions to food under the FoodPrint brand. It also provides clinical analysis to the public, clinics, and health professionals; and supplies Food Detective, a food sensitivity test. In addition, the company offers Gut Detective, a comprehensive stool biomarker panel used to investigate key areas of gut health, including inflammation, digestive enzyme production and intestinal permeability; and CNS Lab, which provides laboratory services for food sensitivity. The company was formerly known as Omega Diagnostics Group PLC and changed its name to Cambridge Nutritional Sciences plc in September 2023. Cambridge Nutritional Sciences plc is based in London, the United Kingdom.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Headquarters
- London, United Kingdom
- Employees
- 85
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.